Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of HIV Integrase Strand Transfer Inhibitors (INSTI) market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of HIV Integrase Strand Transfer Inhibitors (INSTI)market, defines the market attractiveness level of HIV Integrase Strand Transfer Inhibitors (INSTI) market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of HIV Integrase Strand Transfer Inhibitors (INSTI) industry, describes the types of HIV Integrase Strand Transfer Inhibitors (INSTI) market, the applications of major players and the market size, and deeply analyzes the current situation of the global HIV Integrase Strand Transfer Inhibitors (INSTI) market and the development prospects and opportunities of HIV Integrase Strand Transfer Inhibitors (INSTI) industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global HIV Integrase Strand Transfer Inhibitors (INSTI) market in Chapter 13.
By Player:
Gilead Sciences
Affine Formulations Limited
Aurobindo Pharma
Cipla
Emcure Pharmaceuticals
Flamingo Pharmaceuticals Limited
Bristol-Myers Squibb
Biocon Limited
Adcock Ingram Limited
By Type:
Raltegravir
Elvitegravir Combination Drugs
Dolutegravir and Its Combination Drug
Bictegravir Combination Drug
Cabotegravir
Other
By End-User:
Hospital
Clinic
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 HIV Integrase Strand Transfer Inhibitors (INSTI) Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 HIV Integrase Strand Transfer Inhibitors (INSTI) Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise HIV Integrase Strand Transfer Inhibitors (INSTI) Market Analysis and Outlook to 2022
-
7.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Consumption (2017-2022)
-
7.2 United States HIV Integrase Strand Transfer Inhibitors (INSTI) Consumption (2017-2022)
-
7.3 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Consumption (2017-2022)
-
7.4 China HIV Integrase Strand Transfer Inhibitors (INSTI) Consumption (2017-2022)
-
7.5 Japan HIV Integrase Strand Transfer Inhibitors (INSTI) Consumption (2017-2022)
-
7.6 India HIV Integrase Strand Transfer Inhibitors (INSTI) Consumption (2017-2022)
-
7.7 South Korea HIV Integrase Strand Transfer Inhibitors (INSTI) Consumption (2017-2022)
8 Region and Country-wise HIV Integrase Strand Transfer Inhibitors (INSTI) Market Analysis and Outlook to 2028
-
8.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Consumption Forecast (2022-2028)
-
8.2 United States HIV Integrase Strand Transfer Inhibitors (INSTI) Consumption Forecast (2022-2028)
-
8.3 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Consumption Forecast (2022-2028)
-
8.4 China HIV Integrase Strand Transfer Inhibitors (INSTI) Consumption Forecast (2022-2028)
-
8.5 Japan HIV Integrase Strand Transfer Inhibitors (INSTI) Consumption Forecast (2022-2028)
-
8.6 India HIV Integrase Strand Transfer Inhibitors (INSTI) Consumption Forecast (2022-2028)
-
8.7 South Korea HIV Integrase Strand Transfer Inhibitors (INSTI) Consumption Forecast (2022-2028)
9 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Outlook by Types and Applications to 2022
-
9.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Raltegravir Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Elvitegravir Combination Drugs Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Dolutegravir and Its Combination Drug Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Bictegravir Combination Drug Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Cabotegravir Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Outlook by Types and Applications to 2028
-
10.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Raltegravir Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Elvitegravir Combination Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Dolutegravir and Its Combination Drug Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Bictegravir Combination Drug Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Cabotegravir Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Import and Export Analysis (Top 5 Countries)
-
11.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Competitive Analysis
-
14.1 Gilead Sciences
-
14.1.1 Gilead Sciences Company Details
-
14.1.2 Gilead Sciences HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Gilead Sciences HIV Integrase Strand Transfer Inhibitors (INSTI) Product and Service
-
14.2 Affine Formulations Limited
-
14.2.1 Affine Formulations Limited Company Details
-
14.2.2 Affine Formulations Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Affine Formulations Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product and Service
-
14.3 Aurobindo Pharma
-
14.3.1 Aurobindo Pharma Company Details
-
14.3.2 Aurobindo Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Aurobindo Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Product and Service
-
14.4 Cipla
-
14.4.1 Cipla Company Details
-
14.4.2 Cipla HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Cipla HIV Integrase Strand Transfer Inhibitors (INSTI) Product and Service
-
14.5 Emcure Pharmaceuticals
-
14.5.1 Emcure Pharmaceuticals Company Details
-
14.5.2 Emcure Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Emcure Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Product and Service
-
14.6 Flamingo Pharmaceuticals Limited
-
14.6.1 Flamingo Pharmaceuticals Limited Company Details
-
14.6.2 Flamingo Pharmaceuticals Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Flamingo Pharmaceuticals Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product and Service
-
14.7 Bristol-Myers Squibb
-
14.7.1 Bristol-Myers Squibb Company Details
-
14.7.2 Bristol-Myers Squibb HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Bristol-Myers Squibb HIV Integrase Strand Transfer Inhibitors (INSTI) Product and Service
-
14.8 Biocon Limited
-
14.8.1 Biocon Limited Company Details
-
14.8.2 Biocon Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Biocon Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product and Service
-
14.9 Adcock Ingram Limited
-
14.9.1 Adcock Ingram Limited Company Details
-
14.9.2 Adcock Ingram Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Adcock Ingram Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of HIV Integrase Strand Transfer Inhibitors (INSTI)
-
Figure HIV Integrase Strand Transfer Inhibitors (INSTI) Picture
-
Table Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global HIV Integrase Strand Transfer Inhibitors (INSTI) Consumption by Country (2017-2022)
-
Figure United States HIV Integrase Strand Transfer Inhibitors (INSTI) Consumption and Growth Rate (2017-2022)
-
Table Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Consumption and Growth Rate (2017-2022)
-
Figure China HIV Integrase Strand Transfer Inhibitors (INSTI) Consumption and Growth Rate (2017-2022)
-
Figure Japan HIV Integrase Strand Transfer Inhibitors (INSTI) Consumption and Growth Rate (2017-2022)
-
Figure India HIV Integrase Strand Transfer Inhibitors (INSTI) Consumption and Growth Rate (2017-2022)
-
Figure South Korea HIV Integrase Strand Transfer Inhibitors (INSTI) Consumption and Growth Rate (2017-2022)
-
Figure Global HIV Integrase Strand Transfer Inhibitors (INSTI) Consumption Forecast by Country (2022-2028)
-
Figure United States HIV Integrase Strand Transfer Inhibitors (INSTI) Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure China HIV Integrase Strand Transfer Inhibitors (INSTI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan HIV Integrase Strand Transfer Inhibitors (INSTI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure India HIV Integrase Strand Transfer Inhibitors (INSTI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea HIV Integrase Strand Transfer Inhibitors (INSTI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Raltegravir Consumption and Growth Rate (2017-2022)
-
Figure Global Elvitegravir Combination Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Dolutegravir and Its Combination Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Bictegravir Combination Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Cabotegravir Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Raltegravir Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Elvitegravir Combination Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Dolutegravir and Its Combination Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bictegravir Combination Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cabotegravir Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global HIV Integrase Strand Transfer Inhibitors (INSTI) Import by Region (Top 5 Countries) (2017-2028)
-
Table Global HIV Integrase Strand Transfer Inhibitors (INSTI) Export by Region (Top 5 Countries) (2017-2028)
-
Table Gilead Sciences (Foundation Year, Company Profile and etc.)
-
Table Gilead Sciences HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Sciences HIV Integrase Strand Transfer Inhibitors (INSTI) Product and Service
-
Table Affine Formulations Limited (Foundation Year, Company Profile and etc.)
-
Table Affine Formulations Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Affine Formulations Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product and Service
-
Table Aurobindo Pharma (Foundation Year, Company Profile and etc.)
-
Table Aurobindo Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aurobindo Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Product and Service
-
Table Cipla (Foundation Year, Company Profile and etc.)
-
Table Cipla HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cipla HIV Integrase Strand Transfer Inhibitors (INSTI) Product and Service
-
Table Emcure Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Emcure Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Emcure Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Product and Service
-
Table Flamingo Pharmaceuticals Limited (Foundation Year, Company Profile and etc.)
-
Table Flamingo Pharmaceuticals Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Flamingo Pharmaceuticals Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb HIV Integrase Strand Transfer Inhibitors (INSTI) Product and Service
-
Table Biocon Limited (Foundation Year, Company Profile and etc.)
-
Table Biocon Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biocon Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product and Service
-
Table Adcock Ingram Limited (Foundation Year, Company Profile and etc.)
-
Table Adcock Ingram Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Adcock Ingram Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product and Service
-
